Barbara Tempalski

Summary

Affiliation: National Development and Research Institutes
Country: USA

Publications

  1. pmc Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007
    Barbara Tempalski
    Institute for AIDS Research, National Development and Research Institutes, Inc NDRI, New York, New York, United States of America
    PLoS ONE 8:e64789. 2013
  2. pmc HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002
    Barbara Tempalski
    National Development and Research Institutes, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 86:132-54. 2009
  3. pmc Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug
    Barbara Tempalski
    National Development and Research Institutes, Inc, New York, NY, USA
    Int J Drug Policy 19:S47-58. 2008
  4. pmc Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas
    Barbara Tempalski
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Fl, New York, NY 10010, USA
    Subst Abuse Treat Prev Policy 5:23. 2010
  5. pmc Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas
    Barbara Tempalski
    Center for Drug Use and HIV Research, National Development and Research Institutes, Inc, New York, NY 10010, USA
    Am J Public Health 97:437-47. 2007
  6. pmc Drugscapes and the role of place and space in injection drug use-related HIV risk environments
    Barbara Tempalski
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    Int J Drug Policy 20:4-13. 2009
  7. pmc Placing the dynamics of syringe exchange programs in the United States
    Barbara Tempalski
    National Development and Research Institutes, Inc, 71 West 23rd St, 8F, NY 10010, USA
    Health Place 13:417-31. 2007
  8. ncbi request reprint Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America
    Samuel R Friedman
    National Development and Research Institutes, New York, NY 10010, USA
    Int J Drug Policy 18:475-85. 2007
  9. pmc Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDS
    Samuel R Friedman
    Institute of Infectious Disease Research, National Development and Research Institutes, Inc, New York, New York, United States of America
    PLoS ONE 8:e57201. 2013
  10. pmc Residential segregation and injection drug use prevalence among Black adults in US metropolitan areas
    Hannah L F Cooper
    Medical and Health Research Association of New York City, Inc, New York, NY, USA
    Am J Public Health 97:344-52. 2007

Detail Information

Publications22

  1. pmc Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007
    Barbara Tempalski
    Institute for AIDS Research, National Development and Research Institutes, Inc NDRI, New York, New York, United States of America
    PLoS ONE 8:e64789. 2013
    ..Current estimates of PWID and PWID subpopulations will help target services and help to understand long-term health trends among PWID populations...
  2. pmc HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002
    Barbara Tempalski
    National Development and Research Institutes, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 86:132-54. 2009
    ..These results warrant further research into the population dynamics of disease progression, access to health services, and the effects of HIV prevention interventions for IDUs...
  3. pmc Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug
    Barbara Tempalski
    National Development and Research Institutes, Inc, New York, NY, USA
    Int J Drug Policy 19:S47-58. 2008
    ..Notably, we know little about variations in syringe coverage within the U.S. and elsewhere, or about the social and political factors that might determine this coverage...
  4. pmc Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas
    Barbara Tempalski
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Fl, New York, NY 10010, USA
    Subst Abuse Treat Prev Policy 5:23. 2010
    ..Yet, little is known about changes in drug treatment availability for IDUs in the U.S. This paper investigates change in drug treatment coverage for IDUs in 90 metropolitan statistical areas (MSAs) during 1993-2002...
  5. pmc Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas
    Barbara Tempalski
    Center for Drug Use and HIV Research, National Development and Research Institutes, Inc, New York, NY 10010, USA
    Am J Public Health 97:437-47. 2007
    ..Need was not a predictor...
  6. pmc Drugscapes and the role of place and space in injection drug use-related HIV risk environments
    Barbara Tempalski
    National Development and Research Institutes, Inc, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    Int J Drug Policy 20:4-13. 2009
    ..As such, we consider in this commentary the importance of geographic place and the socio-spatial and political processes related to place that may help determine where IDU-related HIV risk environments occur...
  7. pmc Placing the dynamics of syringe exchange programs in the United States
    Barbara Tempalski
    National Development and Research Institutes, Inc, 71 West 23rd St, 8F, NY 10010, USA
    Health Place 13:417-31. 2007
    ..Action on this issue occurs locally, and the characteristics of place-based factors affect whether particular areas adopt SEPs...
  8. ncbi request reprint Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America
    Samuel R Friedman
    National Development and Research Institutes, New York, NY 10010, USA
    Int J Drug Policy 18:475-85. 2007
    ..Here, we determine which metropolitan area characteristics are associated with drug treatment coverage...
  9. pmc Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDS
    Samuel R Friedman
    Institute of Infectious Disease Research, National Development and Research Institutes, Inc, New York, New York, United States of America
    PLoS ONE 8:e57201. 2013
    ..We assess metropolitan area characteristics associated with decline in mortality rates among IDUs living with AIDS (per 10,000 adult MSA residents) after highly active antiretroviral therapy (HAART) was developed...
  10. pmc Residential segregation and injection drug use prevalence among Black adults in US metropolitan areas
    Hannah L F Cooper
    Medical and Health Research Association of New York City, Inc, New York, NY, USA
    Am J Public Health 97:344-52. 2007
    ..We analyzed the relations of two 1990 dimensions of racial residential segregation (isolation and concentration) with 1998 injection drug use prevalence among Black adult residents of 93 large US metropolitan statistical areas (MSAs)...
  11. pmc HIV among injection drug users in large US metropolitan areas, 1998
    Samuel R Friedman
    Institute for AIDS Research, National Development and Research Institutes, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 82:434-45. 2005
    ....
  12. pmc Estimates of the population prevalence of injection drug users among hispanic residents of large US metropolitan areas
    Enrique R Pouget
    National Development and Research Institutes, Inc, New York, NY, USA
    J Urban Health 89:527-64. 2012
    ..Future research should attempt to determine to what extent these trends are applicable to Hispanic national origin subgroups...
  13. pmc Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areas
    Sudip Chatterjee
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    AIDS Behav 15:1570-8. 2011
    ..64) to 2002 (mean = 115.59). Additional analyses of the proportion of young IDUs using health services suggest this increase may have continued after 2002. Harm reduction and prevention research and programs for young IDUs are needed...
  14. pmc Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002
    Joanne E Brady
    Institute for AIDS Research, National Development and Research Institutes, Inc NDRI, 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    J Urban Health 85:323-51. 2008
    ....
  15. pmc Drug arrests and injection drug deterrence
    Samuel R Friedman
    National Development and Research Institutes, Inc, New York, NY 10010, USA
    Am J Public Health 101:344-9. 2011
    ..We tested the hypothesis that higher rates of previous hard drug-related arrests predict lower rates of injection drug use...
  16. pmc Distance traveled and cross-state commuting to opioid treatment programs in the United States
    Andrew Rosenblum
    National Development and Research Institutes, Inc NDRI, 71 W 23 Street, 8th Floor, New York, NY 10010, USA
    J Environ Public Health 2011:948789. 2011
    ..To reduce obstacles to OTP access, policy makers and treatment providers should be alert to patients' commuting patterns and to factors associated with them...
  17. pmc Diffusion of the D.A.R.E and syringe exchange programs
    Don C Des Jarlais
    Beth Israel Medical Center, New York, NY 10038, USA
    Am J Public Health 96:1354-8. 2006
    ..The decision theory concepts of framing and loss aversion may be useful for further research on the diffusion of public health innovations...
  18. ncbi request reprint Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas
    Samuel R Friedman
    National Development and Research Institutes, New York, NY 10010, USA
    AIDS 20:93-9. 2006
    ..To understand associations of punitive policies to the population prevalence of injection drug users and to HIV seroprevalence among injectors...
  19. ncbi request reprint Racial/ethnic disparities in injection drug use in large US metropolitan areas
    Hannah Cooper
    Medical and Health Research Association of New York City, Inc, NY, USA
    Ann Epidemiol 15:326-34. 2005
    ....
  20. pmc Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users
    Samuel R Friedman
    Institute for AIDS Research, National Development and Research Institutes, Inc, New York, NY 10010, USA
    J Urban Health 81:377-400. 2004
    ..Although service provision levels varied considerably, few if any metropolitan areas seemed to be providing adequate levels of services...
  21. pmc A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies
    Brandon D L Marshall
    Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, United States of America
    PLoS ONE 7:e44833. 2012
    ..We describe the development of a conceptual framework and calibration of an agent-based model (ABM) to examine how combinations of interventions may reduce and potentially eliminate HIV transmission among drug-using populations...
  22. pmc Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis
    Hannah L F Cooper
    National Development and Research Institutes, New York, NY, USA
    Clin Infect Dis 45:1200-3. 2007
    ..e., injection drug users) remained stable. Increasing methamphetamine use and/or drug injection frequency may have increased the incidence of infective endocarditis among active injection drug users...